In the study by Su J, it was found that pretreatment with atorvastatin could alleviate the development of CI-AKI, potentially through the inhibition of the Rho/ROCK pathway and the reduction of apoptosis in renal tubular cells (Su et al., 2014). This evidence concerns the gene RHO and acute kidney injury.